annual cash & cash equivalents:
$681.10M+$305.17M(+81.18%)Summary
- As of today (May 29, 2025), BBIO annual cash & cash equivalents is $681.10 million, with the most recent change of +$305.17 million (+81.18%) on December 31, 2024.
- During the last 3 years, BBIO annual cash & cash equivalents has risen by +$287.33 million (+72.97%).
- BBIO annual cash & cash equivalents is now at all-time high.
Performance
BBIO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$540.60M-$140.50M(-20.63%)Summary
- As of today (May 29, 2025), BBIO quarterly cash & cash equivalents is $540.60 million, with the most recent change of -$140.50 million (-20.63%) on March 31, 2025.
- Over the past year, BBIO quarterly cash & cash equivalents has increased by +$65.38 million (+13.76%).
- BBIO quarterly cash & cash equivalents is now -28.59% below its all-time high of $757.05 million, reached on March 31, 2020.
Performance
BBIO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BBIO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +81.2% | +13.8% |
| 3 y3 years | +73.0% | +45.5% |
| 5 y5 years | +87.2% | -28.6% |
BBIO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.2% | -20.6% | +103.0% |
| 5 y | 5-year | at high | +91.3% | -28.6% | +199.8% |
| alltime | all time | at high | +640.4% | -28.6% | +199.8% |
BBIO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $540.60M(-20.6%) |
| Dec 2024 | $681.10M(+81.2%) | $681.10M(+155.7%) |
| Sep 2024 | - | $266.32M(-34.7%) |
| Jun 2024 | - | $407.96M(-14.2%) |
| Mar 2024 | - | $475.22M(+26.4%) |
| Dec 2023 | $375.94M(-0.2%) | $375.94M(-25.6%) |
| Sep 2023 | - | $505.21M(+67.0%) |
| Jun 2023 | - | $302.44M(-25.8%) |
| Mar 2023 | - | $407.37M(+8.1%) |
| Dec 2022 | $376.69M(-4.3%) | $376.69M(-22.0%) |
| Sep 2022 | - | $483.24M(+2.8%) |
| Jun 2022 | - | $470.10M(+26.5%) |
| Mar 2022 | - | $371.55M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $393.77M(+10.6%) | $393.77M(+118.3%) |
| Sep 2021 | - | $180.35M(-52.3%) |
| Jun 2021 | - | $378.42M(-19.7%) |
| Mar 2021 | - | $471.18M(+32.3%) |
| Dec 2020 | $356.08M(-2.1%) | $356.08M(-3.0%) |
| Sep 2020 | - | $366.97M(-32.2%) |
| Jun 2020 | - | $540.92M(-28.5%) |
| Mar 2020 | - | $757.05M(+108.1%) |
| Dec 2019 | $363.77M(-16.6%) | $363.77M(-12.1%) |
| Sep 2019 | - | $413.97M(+40.9%) |
| Jun 2019 | - | $293.80M(-21.2%) |
| Mar 2019 | - | $373.03M(-14.5%) |
| Dec 2018 | $436.09M(+374.0%) | $436.09M |
| Dec 2017 | $92.00M | - |
FAQ
- What is BridgeBio Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BridgeBio Pharma?
- What is BridgeBio Pharma annual cash & cash equivalents year-on-year change?
- What is BridgeBio Pharma quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly cash & cash equivalents year-on-year change?
What is BridgeBio Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of BBIO is $681.10M
What is the all time high annual cash & cash equivalents for BridgeBio Pharma?
BridgeBio Pharma all-time high annual cash & cash equivalents is $681.10M
What is BridgeBio Pharma annual cash & cash equivalents year-on-year change?
Over the past year, BBIO annual cash & cash equivalents has changed by +$305.17M (+81.18%)
What is BridgeBio Pharma quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BBIO is $540.60M
What is the all time high quarterly cash & cash equivalents for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly cash & cash equivalents is $757.05M
What is BridgeBio Pharma quarterly cash & cash equivalents year-on-year change?
Over the past year, BBIO quarterly cash & cash equivalents has changed by +$65.38M (+13.76%)